MARATTO

article · The American Journal of Gastroenterology

Global, Regional, and National Burden of Primary Liver Cancer Attributable to Metabolic Risks: An Analysis of the Global Burden of Disease Study 1990–2021

202512 citationsOpen accessMinia University

Abstract

Primary liver cancer attributable to high BMI and/or high FPG imposes an increasingly substantial clinical burden on global public health, particularly in high SDI countries. Rapid growth trends are also found in middle SDI countries.

Research topics

  • Liver Disease Diagnosis and Treatment
  • Cancer, Lipids, and Metabolism
  • Multiple and Secondary Primary Cancers

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.14309/ajg.0000000000003288

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.